Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Subhra Mandal

Showing results (11-20 of 46) with videos related to

Pageof 5
Sort By:
Frontiers in Pharmacology|January 4, 2021
Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic ExperimentsSimone Perazzolo, Subhra Mandal, Pavan K Prathipati, et al.
Journal of Nanotechnology and Materials Science|June 9, 2018
Nanoparticle Encapsulation for Antiretroviral Pre-Exposure ProphylaxisKarl Khandalavala, Subhra Mandal, Rachel Pham, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2016
An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV InfectionSubhra Mandal, Michael Belshan, Ashley Holec, et al.
Current HIV Research|November 23, 2017
Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV TherapeuticsAshley D Holec, Subhra Mandal, Pavan Kumar Prathipati, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2021
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure ProphylaxisSubhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 11, 2012
Poly-L-lysine-coated silver nanoparticles as positively charged substrates for surface-enhanced Raman scatteringLucia Marsich, Alois Bonifacio, Subhra Mandal, et al.
Pharmaceutical Research|May 22, 2019
Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Pharmaceutical Research|September 15, 2017
Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
B-cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-host Interaction and Damage During Chronic SIV Infection of Rhesus MacaquesYilun Cheng, Miaoyun Zhao, Jackson Chen, et al.
Antiviral Research|June 10, 2018
Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model studySubhra Mandal, Guobin Kang, Pavan Kumar Prathipati, et al.
Pageof 5

Showing results (11-20 of 46) with videos related to

Sort By:
Pageof 5
Frontiers in Pharmacology|January 4, 2021
Bictegravir Plus Tenofovir Alafenamide Nanoformulation as a Long-Acting Pre-Exposure Prophylaxis Regimen: Application of Modeling to Design Non-Human Primate Pharmacokinetic ExperimentsSimone Perazzolo, Subhra Mandal, Pavan K Prathipati, et al.
Journal of Nanotechnology and Materials Science|June 9, 2018
Nanoparticle Encapsulation for Antiretroviral Pre-Exposure ProphylaxisKarl Khandalavala, Subhra Mandal, Rachel Pham, et al.
Antimicrobial Agents and Chemotherapy|November 9, 2016
An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV InfectionSubhra Mandal, Michael Belshan, Ashley Holec, et al.
Current HIV Research|November 23, 2017
Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV TherapeuticsAshley D Holec, Subhra Mandal, Pavan Kumar Prathipati, et al.
Antimicrobial Agents and Chemotherapy|February 2, 2021
A Concept Evaluation Study of a New Combination Bictegravir plus Tenofovir Alafenamide Nanoformulation with Prolonged Sustained-Drug-Release Potency for HIV-1 Preexposure ProphylaxisSubhra Mandal, Pavan Kumar Prathipati, Shawnalyn W Sunagawa, et al.
Langmuir : the ACS Journal of Surfaces and Colloids|September 11, 2012
Poly-L-lysine-coated silver nanoparticles as positively charged substrates for surface-enhanced Raman scatteringLucia Marsich, Alois Bonifacio, Subhra Mandal, et al.
Pharmaceutical Research|May 22, 2019
Correction to: Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Pharmaceutical Research|September 15, 2017
Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice ModelPavan Kumar Prathipati, Subhra Mandal, Gregory Pon, et al.
Biorxiv : the Preprint Server for Biology|December 3, 2025
B-cell Follicles in the Secondary Lymphatic Tissues Act as a Critical Microanatomical Niche for Sustained Viral Replication, Virus-host Interaction and Damage During Chronic SIV Infection of Rhesus MacaquesYilun Cheng, Miaoyun Zhao, Jackson Chen, et al.
Antiviral Research|June 10, 2018
Long-acting parenteral combination antiretroviral loaded nano-drug delivery system to treat chronic HIV-1 infection: A humanized mouse model studySubhra Mandal, Guobin Kang, Pavan Kumar Prathipati, et al.
Pageof 5